RECENT NEWS
Hims & Hers strikes a deal with Novo Nordisk to sell Wegovy — and the stock soars 28%
Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options
Eli Lilly is coming after makers of copycat versions of Zepbound
Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundup